Leszek Drabik

Publications

• https://scholar.google.pl/citations?user=XDwPgpIAAAAJ&hl=pl
• https://www.researchgate.net/profile/Leszek_Drabik
• A successful treatment of ischemic cardiomyopathy associated with left ventricular aneurysm and chronic ischaemic mitral regurgitation (RCD code: III-1B.9.o)
• Evolution of left ventricular function after Wharton's jelly mesenchymal stem cells transcoronary administration : 5-year follow up in a pilot cohort of CIRCULATE-AMI Randomized Trial.
• Krwawienie u chorych z migotaniem przedsionków leczonych przeciwkrzepliwie rozważania praktyczne.
• Autonomic dysfunction in patients with relapsing-remitting multiple sclerosis treated with different oral disease modifying therapies - a pilot study.
• Olfactory dysfunction in patients with relapsing-remitting multiple sclerosis treated with disease modifying therapies.
• Polymorphism in the chemokine receptor 7 gene (CCR7) is associated with previous myocardial infarction in patients undergoing elective coronary angiography
• Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: Association with thrombin generation, endothelial injury and platelet activation
• Badania nad terapiami regeneracyjnymi miokardium w ostrym zawale serca i przewlekłej niedokrwiennej niewydolności serca.
• Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.
• Left atrial myxoma as a cause of multiple cerebral microembolization (RCD code: VI‑1A.1)
• Patient with constrictive pericarditis (RCD code: III).
• Rapid progressive idiopathic pulmonary arterial hypertension (RCD code: II-1A.1).
• An adult patient with tetralogy of Fallot and anomalous left anterior descending artery after conduit type of repair (RCD code: IV-2A.1).
• Partial anomalous pulmonary venous connection (RCD code: II-3C.0).
• Female patient after correction of tetralogy of Fallot with severe pulmonary regurgitation and significant left-to-right shunt at the ventricular septal level (RCD code: IV-5A2).
• Związek polimorfizmów genów dla receptora chemokinowego typu 7 oraz chemokiny CCL19 z miażdżycą naczyń wieńcowych.
• MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity in long-term survivors of acute lymphoblastic leukemia treated with doxorubicin
• Clinical characteristics and medical therapy in randomized clinical trial eligible-and-enrolled vs. eligible-but-not enrolled patients with ischaemic heart failure
• Left atrial myxoma as a cause of multiple cerebral microembolization (RCD code: VI-1A.1)
• Ischemic Versus Non-Ischemic (Neurogenic) Myocardial Contractility Impairment in Acute Coronary Syndromes: Prevalence and Impact on Left Ventricular Systolic Function Recovery.
• Clot Lysis Time Predicts Stroke During Anticoagulant Therapy in Patients with Atrial Fibrillation.
• Non-coding RNA expression profiles and sequence-specificity of transcripts in plasma and extracellular vesiclesEVs in acute lymphoblastic leukemia survivors with the history of anthracycline treatment
• Prevalence and characteristics of patients with solitary coronary artery fistulas in 12,757 all-comer adult patients undergoing coronary angiography.
• Wunderlich's syndrome associated with anticoa- gulant treatment, heart failure, and post-radiation vasculopathy (RCD code: I-O).
• Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
• P1471Multimodality imaging of left ventricular function and volumes in patients with acute and chronic myocardial injury - Novel insights
• Single ventricle function and exercise tolerance in adult patients after Fontan operation.
• P774Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake
• P4604Insights into left ventricular remodelling and clinical outcomes after Wharton's jelly multipotent stem cells transcoronary administration in a pilot cohort of CIRCULATE-AMI Trial (NCT03404063)
• Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran.
• Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies.
• P4018 Reduced fibrin clot permeability is associated with an increased risk of both ischemic stroke and major bleeding in atrial fibrillation patients treated with vitamin K antagonists
• Heparin-induced trombocytopenia in a pregnant woman with factor V Leiden mutation
• P3671Myocardial regeneration strategy using Wharton's jelly multipotent stem cells as an “unlimited” therapeutic agent: 3-year outcomes in a pilot cohort of circulate-acute myocardial infarction trial
• Clinically silent, right and left ventricular outflow tract obstructions in an adult patient (RCD code: IV-3A)
• Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
• The ORBIT bleeding score is associated with lysis and permeability of fibrin clots.
• Unsolved issues of The Efficacy and Safety of Edoxaban
• Bleeding in anticoagulated patients with atrial fibrillation: practical considerations
• Fasting Hyperglycemia and Long-term Outcome in Patients with Acute Ischemic Stroke Treated with Mechanical Thrombectomy.
• Bleeding in anticoagulated patients with atrial fibrillation: practical considerations.
• Routinely Performed Echocardiography and its Impact on Everyday Clinical Practice in Patients admitted to an Internal Medicine Ward.
• Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality.
• NRF2-related transcriptomic alterations as a long-term effect of doxorubicin treatment for childhood acute lymphoblastic leukemia
• Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy.
• Assessment of Left Atrial Function in Patients with Paroxysmal, Persistent, and Permanent Atrial Fibrillation using Two-Dimensional Strain.
• Fasting Normoglycemia after Intravenous Thrombolysis Predicts Favorable Long-Term Outcome in Non-Diabetic Patients with Acute Ischemic Stroke
• Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
• C-Reactive Protein and White Blood Cell Count in Non-Infective Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
• Relationship between left ventricular global longitudinal strain, infarct size and left ventricular function in patients with acute myocardial infarction in a stem cell therapy study
• Assessment of single ventricle diastolic function during stress echocardiography in adult patients after Fontan operation
• Nawrotowe hospitalizacje u starszych chorych z nadciśnieniem tętniczym.
• Rola polimorfizmów genu receptora glukagonopodobnego peptydu 1 (GLP-1R) w cukrzycy typu 2.
• The prognostic role of exercise echocardiography in heart failure.
• Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography - electrospray ionization - mass spectrometry (LC-ESI-MS).
• Neurological Prognostic Factors in Hospitalized Patients with COVID-19
• Brain fog and Quality of Life at Work in Non-hospitalized Patients after COVID-19
• Acute myocardial infarction reparation/regeneration strategy using Wharton’s jelly multipotent stem cells as an ‘unlimited’ therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial
• Endomyocardial transplantation of progenitor cells and risk of transient left ventricular systolic dysfunction
• Eligible-and-enrolled vs. eligible-but-not-enrolled patients with chronic ischaemic heart failure in randomized clinical trials of myocardial regeneration
• SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis
• Fatigue after COVID‐19 in non‐hospitalized patients according to sex
• Objective, observer-independent evaluation of myocardial perfusion and function: role of SPECT.
• Multi-modality imaging in the CIRCULATE-AMI pilot study cohort: a framework for an imaging-based randomized controlled trial of Wharton jelly mesenchymal stem cell use to stimulate myocardial repair/regeneration.
• Trans-endocardial delivery of progenitor cells to compromised myocardium using the "needle technique"and risk of myocardial injury.
• Acute myocardial infarction reparation/regeneration strategy using Wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial.
• Course of fatigue among patients previously hospitalised due to COVID-19.
• Sex-related patient-reported brain fog symptoms in non-hospitalised COVID-19 patients.
• Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis.
• Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
• MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin.
• Response to Letter to the Editors regarding article entitled 'Sex-related patient-reported brain fog symptoms in nonhospitalised COVID-19 patients'.
• Rapid progressive idiopathic pulmonary arterial hypertension (RCD code: II-1A.1)